Oncology

Consensus on COVID-19 Vaccination in Pediatric Oncohematological Patients, on Behalf of Infectious Working Group of Italian Association of Pediatric Hematology Oncology

1. Simone Cesaro
2. Paola Muggeo
3. Daniele Zama
4. Monica Cellini
5. Katia Perruccio
6. Antonella Colombini
7. Francesca Carraro
8. Maria Grazia Petris
9. Valeria Petroni
10. Maurizio Mascarin
11. Francesco Baccelli
12. Elena Soncini
13. Rosamaria Mura
14. Milena La Spina
15. Nunzia Decembrino
16. Roberta Burnelli
17. Stefano Frenos
18. Elio Castagnola
19. Maura Faraci
20. Cristina Meazza
21. Federica Barzaghi
22. Maria Rosaria D’Amico
23. Maria Capasso
24. Elisabetta Calore
25. Ottavio Ziino
26. Angelica Barone
27. Francesca Compagno
28. Laura Luti
29. Federica Galaverna
30. Raffaella De Santis
31. Letizia Brescia
32. Linda Meneghello
33. Angelamaria Petrone
34. Nagua Giurici
35. Daniela Onofrillo
36. Fabian Schumacher
37. Federico Mercolini

Reviewed by ScreenIT

Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant

1. Rajesh M. Valanparambil
2. Jennifer Carlisle
3. Susanne L. Linderman
4. Akil Akthar
5. Ralph Linwood Millett
6. Lilin Lai
7. Andres Chang
8. Ashley A. McCook-Veal
9. Jeffrey Switchenko
10. Tahseen H. Nasti
11. Manpreet Saini
12. Andreas Wieland
13. Kelly E. Manning
14. Madison Ellis
15. Kathryn M. Moore
16. Stephanie L. Foster
17. Katharine Floyd
18. Meredith E. Davis-Gardner
19. Venkata-Viswanadh Edara
20. Mit Patel
21. Conor Steur
22. Ajay K. Nooka
23. Felicia Green
24. Margaret A. Johns
25. Fiona O'Brein
26. Uma Shanmugasundaram
27. Veronika I. Zarnitsyna
28. Hasan Ahmed
29. Lindsay E. Nyhoff
30. Grace Mantus
31. Michael Garett
32. Srilatha Edupuganti
33. Madhusmita Behra
34. Rustom Antia
35. Jens Wrammert
36. Mehul S. Suthar
37. Madhav V. Dhodapkar
38. Suresh Ramalingam
39. Rafi Ahmed

Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer

1. Cong Zeng
2. John P. Evans
3. Karthik Chakravarthy
4. Panke Qu
5. Sarah Reisinger
6. No-Joon Song
7. Mark P. Rubinstein
8. Peter G. Shields
9. Zihai Li
10. Shan-Lu Liu

Reviewed by ScreenIT

Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer

1. Emma Khoury
2. Sarah Nevitt
3. William Rohde Madsen
4. Lance Turtle
5. Gerry Davies
6. Carlo Palmieri

Reviewed by ScreenIT

Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy

1. Thomas Walle
2. Sunanjay Bajaj
3. Joscha A. Kraske
4. Thomas Rösner
5. Christiane S. Cussigh
6. Katharina A. Kälber
7. Lisa Jasmin Müller
8. Sophia Boyoung Strobel
9. Jana Burghaus
10. Stefan M. Kallenberger
11. Christoph K. Stein-Thöringer
12. Maximilian Jenzer
13. Antonia Schubert
14. Steffen Kahle
15. Anja Williams
16. Birgit Hoyler
17. Lin Zielske
18. Renate Skatula
19. Stefanie Sawall
20. Mathias F. Leber
21. Russell Z. Kunes
22. Johannes Krisam
23. Carlo Fremd
24. Andreas Schneeweiss
25. Jürgen Krauss
26. Leonidas Apostolidis
27. Anne Katrin Berger
28. Georg M. Haag
29. Stefanie Zschäbitz
30. Niels Halama
31. Christoph Springfeld
32. Romy Kirsten
33. Jessica C. Hassel
34. Dirk Jäger
35. NCT ANTICIPATE Investigators
36. Christiane S. Cussigh
37. Katharina A. Kälber
38. Omar Abdelrahim
39. Elena Busch
40. Patrick Derigs
41. Katharina Dischinger
42. Fouad Mitri
43. Kerstin Schmidt
44. Irfan A. Bhatti
45. Barbara Grün
46. Nicolas Hohmann
47. Lena Woydack
48. Xin-Wen Zhang
49. Dyke Ferber
50. Andreas Mock
51. Tillmann Pompecki
52. Timo Schank
53. Carlo Fremd
54. Georg M. Haag
55. Niels Halama
56. Romy Kirsten
57. Jessica C. Hassel
58. Dirk Jäger
59. Guy Ungerechts

Reviewed by ScreenIT

Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer

1. Vivek Naranbhai
2. Kerri J. St. Denis
3. Evan C. Lam
4. Onosereme Ofoman
5. Wilfredo F. Garcia-Beltran
6. Cristhian B. Mairena
7. Atul K. Bhan
8. Justin F. Gainor
9. Alejandro B. Balazs
10. A. John Iafrate
11. Ryan J. Sullivan
12. Aditya Bardia
13. Laura M. Spring
14. Steven J. Isakoff
15. Jocelyn R. Farmer
16. Leyre Zubiri
17. Gabriella S. Hobbs
18. Joan How
19. Andrew M. Brunner
20. Amir T. Fathi
21. Clarie A. Pernat
22. A. Gavralidis
23. Jennifer L. Peterson
24. Mustafa Sakhi
25. Grace Hambelton
26. Elyssa N. Denault
27. Lindsey J. Mortensen
28. Lailoo A. Periello
29. Marissa N. Bruno
30. M.N. Bruno
31. Brittany Y. Betraux
32. Alyssa R. Lawless
33. Melissa A. Jackson
34. Elizabeth Niehoff
35. Claire Barabell
36. Christain N. Nambu
37. Erika Nakajima
38. Thomas Reinecke
39. Cyndi Bowes
40. Grace E. Kirkpatrick
41. Julia C. Thierauf
42. Kerri Reynolds
43. Henning Willers
44. Anand S. Dighe
45. Rebecca Saff
46. Kimberley Blumenthal

Reviewed by ScreenIT

Blood Cytokine Analysis Suggests That SARS-CoV-2 Infection Results in a Sustained Tumour Promoting Environment in Cancer Patients

1. Fien H. R. De Winter
2. An Hotterbeekx
3. Manon T. Huizing
4. Angelina Konnova
5. Erik Fransen
6. Bart ’s Jongers
7. Ravi Kumar Jairam
8. Vincent Van averbeke
9. Pieter Moons
10. Ella Roelant
11. Debbie Le Blon
12. Wim Vanden Berghe
13. Annelies Janssens
14. Willem Lybaert
15. Lieselot Croes
16. Christof Vulsteke
17. Surbhi Malhotra-Kumar
18. Herman Goossens
19. Zwi Berneman
20. Marc Peeters
21. Peter A. van Dam
22. Samir Kumar-Singh

Reviewed by ScreenIT

Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer

1. Yohei Funakoshi
2. Kimikazu Yakushijin
3. Goh Ohji
4. Wataru Hojo
5. Hironori Sakai
6. Ryo Takai
7. Taku Nose
8. Shinya Ohata
9. Yoshiaki Nagatani
10. Taiji Koyama
11. Akihito Kitao
12. Meiko Nishimura
13. Yoshinori Imamura
14. Naomi Kiyota
15. Kenichi Harada
16. Yugo Tanaka
17. Yasuko Mori
18. Hironobu Minami

Reviewed by ScreenIT

Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients

1. Cong Zeng
2. John P. Evans
3. Sarah Reisinger
4. Jennifer Woyach
5. Christina Liscynesky
6. Zeinab El Boghdadly
7. Mark P. Rubinstein
8. Karthik Chakravarthy
9. Linda Saif
10. Eugene M. Oltz
11. Richard J. Gumina
12. Peter G. Shields
13. Zihai Li
14. Shan-Lu Liu

Reviewed by ScreenIT

Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling

1. Joseph D Butner
2. Geoffrey V Martin
3. Zhihui Wang
4. Bruna Corradetti
5. Mauro Ferrari
6. Nestor Esnaola
7. Caroline Chung
8. David S Hong
9. James W Welsh
10. Naomi Hasegawa
11. Elizabeth A Mittendorf
12. Steven A Curley
13. Shu-Hsia Chen
14. Ping-Ying Pan
15. Steven K Libutti
16. Shridar Ganesan
17. Richard L Sidman
18. Renata Pasqualini
19. Wadih Arap
20. Eugene J Koay
21. Vittorio Cristini

• Curated by eLife

  Evaluation Summary:

  In this manuscript one novel model was constructed to be predictive of cancer immunotherapy based on three parameters proposed to be associated with treatment efficacy. The parameters are easy to fetch under the clinical setting, so the model is simple for application to help predict potential patients who would benefit from immunotherapy.

  (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. The reviewers remained anonymous to the authors.)

Reviewed by eLife